Diagnostic options · UAE

Single Gene tests in Dubai & UAE

Compare available Single Gene tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

332

Listed price range

2,000.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Single Gene test prices

Showing 76–90 of 332 matching tests.

Single Gene diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4893 CYBB Gene Immunodeficiency Type 34 Genetic Test This test detects pathogenic variants in the CYBB gene associated with X-linked chronic granulomatous disease (CGD).	Peripheral Whole Blood	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CYBB gene", "Exons and intron-exon boundaries of the CYBB gene", "Copy Number Variations (CNV)"] Parameters [] Preparation ["No specific fasting required", "Continue all prescribed medications unless advised otherwise by your physician"] Indications ["Diagnosis of X-linked chronic granulomatous disease (CGD)", "Carrier screening in families with a history of CGD", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 70040-8 ICD-10: D84.8 Clinical summary This test detects pathogenic variants in the CYBB gene associated with X-linked chronic granulomatous disease (CGD).
TEST-2100 CYLD Gene Familial Cylindromatosis Genetic Test This genetic test identifies pathogenic variants in the CYLD gene associated with familial cylindromatosis.	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CYLD gene pathogenic variants", "Single nucleotide variants", "Small insertions/deletions", "Copy number changes"] Parameters [] Preparation [] Indications ["Clinical suspicion of familial cylindromatosis", "Family history of cylindromatosis", "Guidance for surveillance", "Cascade screening"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: D23.9 Clinical summary This genetic test identifies pathogenic variants in the CYLD gene associated with familial cylindromatosis.
TEST-6271 CYP24A1 Gene Hypercalcemia Infantile Type Genetic Test This test identifies genetic variants in the CYP24A1 gene associated with infantile hypercalcemia.	Peripheral whole blood	3 to 4 Weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CYP24A1 gene sequence", "Pathogenic variants in CYP24A1"] Parameters [] Preparation ["Inform laboratory of vitamin D supplements, calcium therapies, or thiazide diuretics"] Indications ["Suspected infantile hypercalcemia type 1", "Family history of CYP24A1-related hypercalcemia"] Measurement technique Confirm with laboratory Codes LOINC: 94868-5 ICD-10: E83.52 Clinical summary This test identifies genetic variants in the CYP24A1 gene associated with infantile hypercalcemia.
TEST-4596 CYP27B1 Gene Test for Vitamin D-Dependent Rickets Type 1 (Genetic) This test evaluates the CYP27B1 gene for mutations associated with Vitamin D-Dependent Rickets Type 1.	Whole Blood, Extracted DNA, or Finger-Prick Blood Spot (FTA Card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CYP27B1 gene sequence variants", "Mutations causing VDDR-1"] Parameters [] Preparation ["Genetic counselling session recommended", "Inform lab of recent blood transfusion"] Indications ["Suspected Vitamin D-Dependent Rickets Type 1", "Family history of VDDR-1", "Carrier screening", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 91851-1 ICD-10: E83.31 Clinical summary This test evaluates the CYP27B1 gene for mutations associated with Vitamin D-Dependent Rickets Type 1.
TEST-2631 DCX Gene Lissencephaly, X-linked Type 1 Genetic Test This test identifies pathogenic variants in the DCX gene, the definitive cause of classic lissencephaly and subcortical band heterotopia.	Whole blood (EDTA) or DNA FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DCX gene", "Exonic variants"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"] Indications ["Suspected X-linked lissencephaly type 1", "Suspected subcortical band heterotopia", "Neuronal migration disorder"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q04.3 Clinical summary This test identifies pathogenic variants in the DCX gene, the definitive cause of classic lissencephaly and subcortical band heterotopia.
TEST-2187 DDX11‑Related Warsaw Breakage Syndrome Genetic Test This genetic test evaluates the DDX11 gene for pathogenic variants associated with Warsaw breakage syndrome.	Whole blood, extracted DNA, or dried blood spot on FTA card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DDX11 gene sequence", "Pathogenic variants in DDX11"] Parameters [] Preparation ["Prior genetic counselling to map family history is mandatory."] Indications ["Suspected Warsaw breakage syndrome", "Family history of chromosome instability disorders", "Guidance for oncology surveillance", "Reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 95451-2 ICD-10: Q87.8 Clinical summary This genetic test evaluates the DDX11 gene for pathogenic variants associated with Warsaw breakage syndrome.
TEST-2879 DHCR24 Gene Desmosterolosis Sequencing Test This test detects pathogenic variants in the DHCR24 gene to confirm a diagnosis of desmosterolosis.	Whole blood (EDTA), Dried blood spot (FTA card), or Extracted DNA	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DHCR24 gene", "Cholesterol biosynthesis pathway disruption"] Parameters [] Preparation ["No specific fasting required.", "Do not discontinue prescribed medications without consulting a physician."] Indications ["Children with dysmorphic features", "Children with developmental delay", "Family history of cholesterol biosynthesis disorders"] Measurement technique Confirm with laboratory Codes LOINC: 101440-4 ICD-10: E78.8 Clinical summary This test detects pathogenic variants in the DHCR24 gene to confirm a diagnosis of desmosterolosis.
TEST-5534 DNAI2 Gene Primary Ciliary Dyskinesia Type 9 Genetic Test This test identifies pathogenic variants in the DNAI2 gene associated with primary ciliary dyskinesia type 9.	Whole Blood (FTA Card or EDTA tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DNAI2 gene mutations", "Pathogenic variants (SNVs, indels, copy-number variants)"] Parameters [] Preparation [] Indications ["Suspected primary ciliary dyskinesia", "Recurrent respiratory infections", "Family history of PCD"] Measurement technique Confirm with laboratory Codes LOINC: 21656-2 ICD-10: J98.09 Clinical summary This test identifies pathogenic variants in the DNAI2 gene associated with primary ciliary dyskinesia type 9.
TEST-4321 DNM1 Gene Early Infantile Epileptic Encephalopathy Type 31 NGS Test This test identifies pathogenic variants in the DNM1 gene associated with Early Infantile Epileptic Encephalopathy Type 31.	Peripheral whole blood (EDTA) or dried blood spot on FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DNM1 gene sequence", "Pathogenic variants (SNVs, indels) in DNM1"] Parameters [] Preparation [] Indications ["High pre-test suspicion of Early Infantile Epileptic Encephalopathy Type 31 (EIEE31)", "Need for definitive molecular confirmation of EIEE31"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G40.4 Clinical summary This test identifies pathogenic variants in the DNM1 gene associated with Early Infantile Epileptic Encephalopathy Type 31.
TEST-4307 DNM1L Gene Encephalopathy, Lethal, Due to Defective Mitochondrial and Peroxisomal Fission Test This genetic test detects pathogenic variants in the DNM1L gene associated with a severe, often lethal, neonatal encephalopathy.	Whole Blood (EDTA), Extracted DNA, or One Drop of Blood on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DNM1L gene", "Defective mitochondrial and peroxisomal fission"] Parameters [] Preparation ["Pre-test genetic counselling session is mandatory", "Pedigree chart construction required"] Indications ["Suspected DNM1L-related encephalopathy", "Infants with severe neurological symptoms and family history"] Measurement technique Confirm with laboratory Codes LOINC: 92860-6 ICD-10: G31.81 Clinical summary This genetic test detects pathogenic variants in the DNM1L gene associated with a severe, often lethal, neonatal encephalopathy.
TEST-4537 DPM1 Gene Glycosylation Disorder Type 1E Genetic Test This genetic test identifies pathogenic variants in the DPM1 gene associated with Congenital Disorder of Glycosylation Type 1E (CDG-1E).	Whole Blood (venous), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DPM1 gene", "Protein glycosylation disruption"] Parameters [] Preparation ["No fasting required unless specified by physician", "Mandatory genetic counselling session required prior to sample collection", "Provide a detailed three-generation pedigree and clinical history"] Indications ["Suspected Congenital Disorder of Glycosylation Type 1E (CDG-1E)", "Individuals with severe neurological impairments and developmental delay", "Family history of CDG-1E"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: E74.8 Clinical summary This genetic test identifies pathogenic variants in the DPM1 gene associated with Congenital Disorder of Glycosylation Type 1E (CDG-1E).
TEST-6353 DPM3 Gene CDG Type 1O (NGS) Genetic Test This test analyzes the DPM3 gene for mutations associated with Congenital Disorder of Glycosylation Type 1O.	Whole blood, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DPM3 gene sequence", "Deletions/Duplications in DPM3 gene"] Parameters [] Preparation ["Do not discontinue any prescribed medication without consulting your doctor."] Indications ["Suspected Congenital Disorder of Glycosylation Type 1O", "Family history of CDG type 1O"] Measurement technique Confirm with laboratory Codes LOINC: 81267-0 ICD-10: E77.8 Clinical summary This test analyzes the DPM3 gene for mutations associated with Congenital Disorder of Glycosylation Type 1O.
TEST-4856 DSG1 Gene Sequencing Test for Keratosis Palmoplantaris Striata Type 1 This diagnostic test evaluates the DSG1 gene for pathogenic variants associated with striate palmoplantar keratoderma type 1 (SPPK1).	Peripheral whole blood, serum, plasma, or FTA card (dried blood spot)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DSG1 gene"] Parameters [] Preparation [] Indications ["Suspected diagnosis of striate palmoplantar keratoderma type 1 (SPPK1)", "Familial risk stratification for SPPK1"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q82.8 Clinical summary This diagnostic test evaluates the DSG1 gene for pathogenic variants associated with striate palmoplantar keratoderma type 1 (SPPK1).
TEST-6133 EARS2 Gene Combined Oxidative Phosphorylation Deficiency Type 12 Genetic Test This genetic test evaluates the EARS2 gene for mutations associated with combined oxidative phosphorylation deficiency type 12, a rare mitochondrial disorder.	Whole Blood (EDTA) or Dried Blood Spot (FTA Card)	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["EARS2 gene sequence", "Single nucleotide variants", "Small insertions/deletions"] Parameters [] Preparation ["Mandatory genetic counselling session prior to sample collection"] Indications ["Evaluation of unexplained metabolic decompensation", "Investigation of lactic acidosis", "Assessment of multisystem involvement", "Diagnosis of combined oxidative phosphorylation deficiency type 12"] Measurement technique Confirm with laboratory Codes LOINC: 90263-4 ICD-10: E88.49 Clinical summary This genetic test evaluates the EARS2 gene for mutations associated with combined oxidative phosphorylation deficiency type 12, a rare mitochondrial disorder.
TEST-5179 EDARADD Gene Ectodermal Dysplasia, Hypohidrotic, Autosomal Recessive Genetic Test This test evaluates the EDARADD gene for pathogenic variants associated with hypohidrotic ectodermal dysplasia (HED). It uses Next-Generation Sequencing (NGS) to provide comprehens...	Whole Blood (EDTA), FTA Card, or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the EDARADD gene", "Copy Number Variants (CNVs) within the EDARADD gene", "Exons and splice sites of the EDARADD gene"] Parameters [] Preparation ["No specific fasting required", "No special medication or diet restrictions"] Indications ["Clinical suspicion of Hypohidrotic Ectodermal Dysplasia (HED)", "Family history of HED", "Need for definitive molecular diagnosis for genetic counselling", "Prenatal diagnosis in affected families"] Measurement technique Confirm with laboratory Codes LOINC: 101174-7 ICD-10: Q82.4 Clinical summary This test evaluates the EDARADD gene for pathogenic variants associated with hypohidrotic ectodermal dysplasia (HED). It uses Next-Generation Sequencing (NGS) to provide comprehensive analysis.

Category overview

Single Gene: overview

When clinical symptoms or family history point directly toward a specific inherited condition, highly focused genetic testing provides the exact, rapid insights necessary for peace of mind. Integrated into our advanced Molecular Genetics services, Single Gene testing meticulously analyzes one specific gene for known disease-causing mutations. Utilizing cutting-edge diagnostic technology, this highly focused molecular screening helps confirm or rule out precise genetic traits, safely guiding targeted medical interventions and family planning strategies. Recognized for specialized diagnostic excellence among diagnostic labs in the UAE, DNA Labs ensures absolute patient confidentiality, exceptional analytical precision, and incredibly efficient turnaround times. Take an informed step forward in your health journey—schedule your single gene testing in UAE, book a secure home sample collection, or reach out to our expert medical professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.